An intriguing new study demonstrating that MYC family amplifications and Trp53 pathway defects both emerged at relapse may provide support for this cooperativity [23] and may imply that loss of Trp53 function is associated with tumor progression. The gene discussed is TP53; the disease is neoplasm.